Inhibitory axons in the lobster nervous system contain about 100 times more gamma-aminobutyric acid (GABA) than excitatory axons, the respective concentrations being about 0.1 M and 0.001 M.' In an attempt to account for this concentration difference, we have begun a study of the enzymes and substrates of GABA metabolism in single excitatory and inhibitory axons. The work was carried out in two phases; first, the pathway of formation and destruction of GABA in the lobster nervous system was established and a study was made of the properties of the enzymes involved; and second, sensitive microassays for the relevant enzymes and substrates were devised and these components were measured in single cells.
metabolism in single excitatory and inhibitory axons. The work was carried out in two phases; first, the pathway of formation and destruction of GABA in the lobster nervous system was established and a study was made of the properties of the enzymes involved; and second, sensitive microassays for the relevant enzymes and substrates were devised and these components were measured in single cells.
Materials and Methods.-Animals: Live lobsters (Homarus americanus) were obtained from a local shipper. Generally, 1.5-kg animals were used.
Preparation of central nervous system (CNS) enzymes: Ganglia and connectives of the CNS were homogenized in Kontes Duall tubes in 0.02 M potassium phosphate, pH 7.2, 0.01 M #3-mercaptoethanol, and 10-4 M pyridoxal phosphate (this solution is hereafter called buffer). This and all subsequent steps were carried out at 4°. The homogenate was centrifuged at 1000 X g, the supernatant fluid collected and centrifuged again at 40,000 X g. The supernatant solution was then fractionated with solid (NH4)2S04. The fraction precipitating between 35 and 60 per cent saturation was collected, dissolved in a small volume of buffer, and dialyzed against 500 vol of buffer overnight.
Enzyme assays: Glutamic decarboxylase activity was measured by collecting C1402 released from glutamate-U-C14 by a micromodification of published methods.2' 3 GABA-glutamic transaminase activity was measured by conversion of GABA-U-C"4 to radioactive succinic semialdehyde and succinate. The method is similar to the microassay procedure described in the legend of Table 1 . Succinic semialdehyde dehydrogenase activity was measured either by conversion of radioactive succinic semialdehyde to radioactive succinate or spectrophotometrically by measuring NADH production. The details of the enzyme assay procedures and kinetic studies will be published shortly.
Single fiber studies: The methods of obtaining and identifying single nerve fibers have already been published.1 The experimental procedures for measuring enzymes and substrates in single axons are described in the legend of Table 1 .
Results and Discussion.-The pathway of GABA metabolism and the properties of the enzymes in the pathway were determined with soluble enzyme extracts prepared from the lobster CNS. The pathway was the same as in the mammalian CNS,4 GABA being formed from glutamic acid by decarboxylation and metabolized through succinic semialdehyde to succinate by transamination and dehydrogenation (Fig. 1) . Kinetic properties and conditions for optimum activity were determined 3-,ul aliquots could be withdrawn for the transaminase and decarboxylase assays. The decarboxylase reaction was started by adding glutamate-U-C"4 (0.3 pmole, 23 lsc/pmole) and the final incubation volume was 5 ,ul. At the end of 1 hr (250) the reaction was stopped by heating and the material applied to a Dowex-l-acetate column. The product was recovered by washing with 5 ml of water. For the transaminase assay NAD + (60 mpmoles), a-ketoglutarate (40 mpmoles), succinate (20 mpmoles), and GABA-U-C14 (60 mpmoles, 19 pc/bumole) were added to the tubes and the final incubation volume was 20 AL. After 1 hr trichloroacetic acid was added (final concentration 5%) and the suspensions poured over Dowex-50-H + columns. Again the product was obtained by washing with 5 ml H20. Unlabeled succinate was added to transaminase incubations and GABA to decarboxylase incubations to protect any radioactive product formed from further metabolism. The amounts of succinate and GABA added did not inhibit the enzymes. (B) Assays for a-ketoglutarate and GABA were carried out by the enzymic procedure of Jakoby and Scott.6 The detailed description of the method for GABA measurement has already been published.' Glutamate was converted to GABA with a bacterial decarboxylase and measured as above.
for each of the enzymes. During the course of these studies it was observed that glutamic decarboxylase is markedly inhibited by its product, GABA. This is illustrated in Figure 2 where the effects of two GABA concentrations on enzyme velocity are graphed by the method of Lineweaver and Burk.5 In the presence of GABA, curves are obtained rather than straight lines, indicating a deviation from classical competitive inhibition kinetics. The enzyme is being further purified to investigate this anomalous behavior.
Next, microassays were devised for the decarboxylase and transaminase so that the activities could be measured in single axons. Succinic semialdehyde dehydro- genase was not measured since experiments showed that it was not rate-limiting for the removal of GABA. The microassay procedures for the decarboxylase and transaminase are similar. In both assays high specific activity C'4 substrates are incubated with homogenates of single excitatory and inhibitory axons. At the end of the incubation periods, the radioactive products are separated from the starting materials with ion exchange columns. The radioactivity in a portion of the product is measured and the remainder can be used for chromatographic analysis to verify the identity of the reaction products. Table 1A shows a representative experiment in which the activities of both enzymes were measured on aliquots from the same homogenates of inhibitory and excitatory axons. There is a marked difference in decarboxylase activity between the two axons, about 11 times more activity being found in the inhibitory axon. The activity in the excitatory axon is near the limit of sensitivity of the method, and this value is therefore uncertain. In the presence of 0.1 M GABA the activity in the inhibitory axon homogenate is reduced by about 65 per cent. In contrast, under the same conditions, a 90 per cent inhibition is observed with the soluble decarboxylase. This is a consistent difference which may reflect differences in the properties of the enzyme in a homogenate and in a soluble dialyzed extract. The transaminase activity in the two fibers differs by a much smaller factor, being about 1.6 times higher in the inhibitory axon.
We have arbitrarily measured the enzyme activities at pH 7.5. The internal pH of the axons is not known but is presumed to be close to neutrality. At pH 7 the decarboxylase activity is about the same as at pH 7.5. The variation of transa-minase activity with pH depends on both the GABA and a-ketoglutarate concentrations. At the concentrations of these compounds measured in the inhibitory axon, there is little change of activity with pH over the range 7.0-7.5, while at the GABA and a-ketoglutarate concentrations found in the excitatory axon, the activity at pH 7.0 is about 2/3 that found at pH 7.5. Thus in the excitatory axon the ratio of decarboxylase to transaminase activity is a function of pH.
Substrate analyses (Table 1B) show the glutamate concentration to be slightly higher in the excitatory axon, and a-ketoglutarate concentration to be the same in both fibers. GABA is, as previously reported, present in much higher concentrations in the inhibitory axon. It should be noted that at the GABA and glutamate concentrations existing in inhibitory axons, the decarboxylase is markedly inhibited (90% in soluble extracts, 65% in single cell homogenates), while at the concentrations that exist in the excitatory axons there is only slight (< 10%) inhibition of enzyme activity.
A point of major interest in considering the metabolism of GABA is the question of whether this compound is found in particles in the axoplasm. A bound form of GABA has been described in the mammalian CNS,7 8 but we have no evidence that such a form of GABA is present in the lobster nervous system. Mloreover, the data in Table 1 are consistent with the idea that the high level of GABA in inhibitory axons can be maintained without sequestering any of the elements in this metabolic pathway, i.e., that enzymes and substrates are freely accessible to each other. The inhibitory axon has the capacity to synthesize more GABA than it can destroy [100 vs. 33 /.L4moles/(cm) (hr)]. Synthesis would only balance destruction at a high (0.1 M) level of GABA where the decarboxylase would be markedly inhibited [34 jsjsmoles/(cm) (hr) ]. If the GABA level in the inhibitory fiber should fall for any reason, the inhibition of the decarboxylase would be diminished and GABA would accumulate until the steady-state concentration was re-established. Therefore the high decarboxylase activity and the GABA inhibition together could provide a means of stabilizing the high GABA level in the inhibitory axon. There are, of course, other possible explanations for the maintenance of a high GABA level in inhibitory axons. Regardless of whether the above hypothesis for GABA accumulation proves to be correct or not, the principal difference between excitatory and inhibitory axons (other than GABA itself) is in the activity of glutamic decarboxylase. This therefore seems likely to be the key to the difference in GABA concentration between the two axons.
Summary.-Lobster inhibitory axons contain about 100 times more gammaaminobutyric acid (GABA) than excitatory axons. A study of the metabolism of GABA in isolated axons demonstrated that GABA-glutamic transaminase, a-ketoglutarate, and glutamate were found in similar amounts in the two types of axons. The activity of glutamic decarboxylase was about 11 times higher in inhibitory axons and it was demonstrated that GABA markedly inhibits this enzyme. It is suggested that the high decarboxylase activity and its GABA inhibition could provide a means of stabilizing the high GABA level found in inhibitory axons. Estrogens, as well as other steroid hormones, may exert their stimulatory effect on target tissues by initial activation of RNA synthesis. 1 2 This concept is supported by the observation that estrogen stimulation of the uterus leads quickly to an increase in the rate of incorporation of precursors into RNA,3 4 the initial increase being noted in the nuclear fraction of RNA.5 The uterotrophic action of estradiol-17f3 is prevented by the metabolic inhibitor actinomycin D either administered systemically6 or by injection into the lumen of the uterus.7 The action of estrogen on the vagina can be prevented also by topical application of actinomycin.5 A mechanism for the effect of estradiol on RNA synthesis has been suggested by the identification of a macromolecular fraction of the cell which possesses receptors for the hormone. This fraction, when not combined with the hormone, inhibits the activity of RNA polymerase. When the hormone is present, the inhibition is released.9 The biochemical evidence that the biosynthesis of RNA by rat uteri is immediately accelerated by estrogen suggests that the stimulating hormone may have no further role in causing the transition from the atrophic to the stimulated state. To test this postulate, RNA was extracted from the uteri of estrogen-stimulated rats and administered by local, intraluminal application to estrogen-deprived ovariectomized rats. The resultant morphologic changes in treated uteri are indistinguishable from those that occur following the administration of estrogen.10 Materials and Methods.-Preparation of total RNA extract: Method A: Female rats of the Sprague-Dawley strain weighing 180-200 gm were ovariectomized, and the certainty of anestrus was established by following the vaginal smears for at least two weeks. Each batch of RNA was prepared from the uteri of at least ten ovariectomized females but frequently as many as 100 were used. Each animal was injected intravenously (tail vein) with 10 jsg estradiol-17,3 per 1 ml 1% ethyl alcohol in saline. After 4 hr, the animals were sacrificed by decapitation; the uteri were removed and quickly frozen. In the 4°C cold room, the uteri were homogenized with a Virtis homogenizer in 10 times volume of saline, with or without 0.001 M MgCl2. The tissue brei was filtered through one layer of cheesecloth and mixed with an equal volume of watersaturated phenol. The mixture was stirred vigorously on a magnetic stirrer for 30 min at room temperature, and the stirring was repeated for 30 min in the 4°C cold room. It was centrifuged at 2,000 gravities for 30-60 min at 2-4°C, and the top aqueous layer was saved. The other layers were washed once with an equal volume of saline, centrifugation was repeated, and the saline was combined with the original supernatant with extreme care to avoid carrying over any saline-
